Mechanisms underlying neuronal degeneration in Parkinson's disease: An experimental and theoretical treatise
- 1 January 1989
- journal article
- review article
- Published by Wiley in Movement Disorders
- Vol. 4 (S1) , S15-S25
- https://doi.org/10.1002/mds.870040504
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- Neurotoxins, parkinsonism and Parkinson's diseasePharmacology & Therapeutics, 1987
- Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomesBiochemical and Biophysical Research Communications, 1985
- Melanin Affinity of 1‐Methyl‐4‐phenyl‐1,2,5,6‐tetrahydropyridine, an Inducer of Chronic Parkinsonism in HumansActa Pharmacologica et Toxicologica, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Possible role of neuromelanin in the pathogenesis of Parkinson's diseaseMechanisms of Ageing and Development, 1983
- Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine Levels in human basal gangliaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1976
- LIPOPROTEIN PIGMENTS—THEIR RELATIONSHIP TO AGEING IN THE HUMAN NERVOUS SYSTEMBrain, 1974
- The Pharmacology of 6-HydroxydopamineAnnual Review of Pharmacology, 1973